SCHEMBL19775751

SCHEMBL19775751

O=[N+]([O-])c1cc(F)c(F)c(OCC2CO2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.43
WDR77 Q9BQA1 1/20 0.43
ALDH1A1 P00352 3/20 0.39
PKM P14618 2/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
GLA P06280 1/20 0.38
DRD4 P21917 3/20 0.36
TP53 P04637 1/20 0.36
CYP3A4 P08684 1/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HIF1A Q16665 1/20 0.36
S1PR4 O95977 1/20 0.36
CYP19A1 P11511 2/20 0.35
TDP1 Q9NUW8 1/20 0.34
PTPN2 P17706 1/20 0.33
PTPN1 P18031 1/20 0.33
PTPN6 P29350 1/20 0.33
PTPN11 Q06124 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21469022 1.00 PRMT5 (0.43) PRMT5WDR77ALDH1A1PKMLMNA
SCHEMBL28723953 0.89 DRD4 (0.39) PRMT5WDR77DRD4TSHRSMN1; SMN2
SCHEMBL28723955 0.89 DRD4 (0.39) PRMT5WDR77DRD4TSHRSMN1; SMN2
SCHEMBL21468971 0.84 PRMT5 (0.38) PRMT5WDR77ALDH1A1PKMLMNA
SCHEMBL5963778 0.83 S1PR4 (0.52) PRMT5WDR77ALDH1A1PKMLMNA
SCHEMBL21459911 0.82 S1PR4 (0.37) PRMT5WDR77ALDH1A1PKMLMNA
SCHEMBL21459912 0.82 S1PR4 (0.37) PRMT5WDR77ALDH1A1PKMLMNA
SCHEMBL23552189 0.81 PRMT5 (0.36) PRMT5WDR77ALDH1A1PKMLMNA
SCHEMBL19776487 0.81 PRMT5 (0.36) PRMT5WDR77ALDH1A1PKMLMNA
SCHEMBL6211440 0.76 ALDH1A1 (0.39) PRMT5WDR77ALDH1A1PKMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018013776-A1 TRICYCLIC HETEROARYL-SUBSTITUTED QUINOLINE AND AZAQUINOLINE COMPOUNDS AS PAR4 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-01-18 WO disclosed